Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension (2023)
Fonte: European respiratory journal. Unidade: FM
Assuntos: SOBREVIDA, HIPERTENSÃO PULMONAR
ABNT
HUMBERT, Marc et al. Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension. European respiratory journal, v. 61, n. 1, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52885. Acesso em: 23 abr. 2024.APA
Humbert, M., Mclaughlin, V., Gibbs, J. S. R., Gomberg-Maitland, M., Hoeper, M. M., Preston, I. R., et al. (2023). Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension. European respiratory journal, 61( 1). doi:10.1183/13993003.01347-2022NLM
Humbert M, Mclaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R de, Waxman AB, Ghofrani H-A, Subias PE. Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension [Internet]. European respiratory journal. 2023 ; 61( 1):[citado 2024 abr. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52885Vancouver
Humbert M, Mclaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R de, Waxman AB, Ghofrani H-A, Subias PE. Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension [Internet]. European respiratory journal. 2023 ; 61( 1):[citado 2024 abr. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52885